After the transaction, Sanderling Venture Partners Vi Co Investment Fund LP's stake was reported as 882,562 shares of Pacira Pharmaceuticals, Inc stock. In addition, Sanderling Venture Partners Vi Co Investment Fund LP performed several other transactions, including using transaction codes 'J'.
As noted on January 25, 2013, Sanderling Venture Partners Vi Co Investment Fund LP's sale was done directly over 1 transaction on January 24, 2013. The share price for the transaction was $18.93 according to the regulatory filing detailing the trade.
If we look over the past 12 months, Sanderling Venture Partners Vi Co Investment Fund LP has sold a total of 500,000 shares of Pacira Pharmaceuticals, Inc, proceeds from the sale totaled $9,465,000. Over the same time period, Sanderling Venture Partners Vi Co Investment Fund LP has purchased no shares of Pacira Pharmaceuticals, Inc stock. Sanderling Venture Partners Vi Co Investment Fund LP has also performed other transactions including used transaction code "J" .
Let's take a quick, high-level look at insider trading at Pacira Pharmaceuticals, Inc over the past 12 months. A total of 785,500 shares of Pacira Pharmaceuticals, Inc stock was sold by insiders, totaling $12,605,306. Over the same time 12 month time period, 5,902,854 shares of Pacira Pharmaceuticals, Inc, for a total value of $41,347,478 were purchased by company insiders.
To view the complete SEC Filing: Pacira Pharmaceuticals, Inc Form 4 (Insider Trading) SEC Filing
